Sex (male)
|
234 (69%)
|
799 (65%)
|
0.2
|
Age (years, mean +/-SD)
|
63+/- 7
|
67+/- 8
|
<0.001
|
BMI (kg/m2, mean +/-SD)
|
31+/- 4
|
30+/- 3
|
0.091
|
Type of AF
|
|
|
<0.001
|
Paroxysmal
|
274 (82%)
|
851 (70%)
|
|
Persistent
|
60 (18%)
|
371 (30%)
|
|
Left Atrium Diameter (cm, mean +/-SD)
|
3.85 +/- 0.6
|
4.30 +/-0.5
|
0.2
|
Coronary Artery Disease (%)
|
63 (18%)
|
259 (21%)
|
0.2
|
Diabetes Mellitus (%)
|
58 (17%)
|
201 (16%)
|
0.9
|
Hypertension (%)
|
187 (54%)
|
740 (60%)
|
0.033
|
Obstructive Sleep Apnea (%)
|
66 (19%)
|
225 (18%)
|
0.8
|
Pre-procedure antiarrhythmic use
|
198 (61%)
|
882 (72%)
|
<0.001
|
Procedural Details |
|
|
|
CTI dependent Atrial Flutter
|
64 (18%)
|
248 (20%)
|
0.5
|
Additional Ablations Performed
|
145 (45%)
|
928 (76%)
|
<0.001
|
Extra Vein Triggers Noted
|
13 (4.0%)
|
149 (12%)
|
<0.001
|
Adenosine Used to Check for
Dormant Conduction
|
215 (67%)
|
779 (63%)
|
0.2
|
Post-procedure Amiodarone use
|
111 (32%)
|
708 (58%)
|
<0.001
|
Post-procedure Dronederone use
|
20 (5.8%)
|
105 (8.6%)
|
0.090
|